Best Immunotherapy For Prostate Cancer Doctors in Turkey for Australians

The doctor is a highly experienced Turkish medical oncologist specializing in sarcoma, lymphoma, pancreatic, lung cancer, and breast cancer. With over 20 years of experience, the doctor focuses on tumor biology, tumor immunology, cancer immunotherapy, and targeted therapies. Since 2019, the doctor has been serving as a medical oncologist at Anadolu Medical Center and previously held leadership roles at Istanbul Okan University Faculty of Medicine and GATA Haydarpaşa Training Hospital. The doctor has authored over 40 publications in cancer research and is a member of the Turkish Medical Oncology Association and the European Head and Neck Society.

The doctor is a highly regarded oncologist at the Anadolu Medical Center, specializing in medical oncology and chemotherapy. After obtaining a medical degree from Ankara University in 2005, the doctor completed specialty training in internal medicine at Istanbul University and further specialized in medical oncology at Marmara University by 2017. The doctor has led the medical oncology unit at Haydarpaşa Numune Training and Research Hospital and has participated in numerous international clinical studies. The doctor focuses on a wide range of cancers, including breast, urological, lung, and gastrointestinal cancers, among others.

The doctor is a member of several prestigious oncology societies, including the Turkish Society of Medical Oncology, the European Society of Medical Oncology, and the American Society of Medical Oncology. The doctor has participated in advanced training programs globally, including programs at Oxford University and ESMO.

The doctor graduated from the School of Medicine at Hacettepe University and completed residency at Istanbul Sisli Etfal Training and Research Hospital, followed by a fellowship at the Hacettepe University Cancer Institute.

Specializing in oncology, the doctor has extensive experience in treating various cancers, including breast, testicular, ovarian, lung, head and neck, and gastrointestinal cancers.

The doctor has worked at prestigious institutions such as The University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital, specialising in complex systemic therapies for advanced malignancies.

• Holds a professorship in medical oncology – the highest academic rank in the field
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Specialised in neuroendocrine tumours through the European Neuroendocrine Tumour Society (ENET)
• Fellowship trained at Istanbul University – Turkey's most prestigious medical institution

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

The doctor specializes in managing breast cancer, colorectal, and urogenital system cancers. With extensive experience since 2014 at Anadolu Medical Center, the doctor has previously served at Medical Park Hospital, Kocaeli Derince Education and Research Hospital, and Erzurum Regional Education and Research Hospital. The doctor's military service included a role as a Medical Oncology specialist at Gülhane Military Medical Academy.

Educational achievements include a degree in general medicine from Istanbul University and specializations in internal medicine and medical oncology. The doctor is a member of the Turkish Medical Association, the Turkish Medical Oncology Society, and the Turkish Lung Cancer Society.

Prof. Yeşim (Yesim) Yıldırım — Medical Oncologist at Anadolu Medical Center (since 2011). ESMO-certified specialist, Professor since 2021, author of 80+ scientific publications. Trained at top centers — Rambam (Israel) and Mount Vernon (UK). Treats breast, lung, and gastrointestinal (GI) cancers, as well as melanoma and sarcomas; uses immunotherapy and targeted therapy.

Why patients choose Dr. Yeşim Yıldırım:

• 20+ years of clinical practice; Professor of Medical Oncology since 2021.
• 80+ peer-reviewed publications in tumor biology, immunotherapy, and targeted therapy — treatment plans are based on up-to-date evidence.
• ESMO certification — from Europe’s leading oncology society — confirms high qualification and continuous training to international standards.

The doctor is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience, specializing in solid cancer, breast cancer, colorectal, and lung cancer treatment. Since 2016, the doctor has been a medical oncology specialist at Anadolu Medical Center.

The doctor graduated from Gülhane Military Medical Academy with a degree in general medicine and completed specialties in internal and medical oncology. The doctor has been a professor and associate professor at Gülhane Military Medical Academy, contributing significantly to medical education.

With over 110 papers on cancer management, the doctor is a member of several prestigious oncology organizations.

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Cemil Bilir is a leading medical oncologist specialising in molecular oncology and the latest immunotherapy protocols for urological cancers.

• Completed a research fellowship at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Serves as a Professor at Sakarya University Faculty of Medicine – one of Turkey's established medical schools
• Active member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO)
• Participates in international clinical trials to provide patients with emerging cancer therapies

Professor Irfan Cicin is a senior medical oncologist who leads the oncology department at Trakya University Faculty of Medicine. He specialises in systemic treatments for complex urological cancers at İstinye University Liv Hospital Topkapı.

• Holds a full professorship in oncology, training the next generation of cancer specialists
• Completed senior fellowship training in medical oncology at Trakya University
• Published extensive research on medical oncology protocols and internal medicine
• Member of the Turkish Society of Medical Oncology

Professor Mustafa Serkan Alemdar is a dual-specialised medical oncologist and internal medicine expert at the JCI-accredited Medical Park Antalya Hospital Complex.

• Completed specialist oncology training at Akdeniz University Faculty of Medicine
• Expertise includes managing targeted immunotherapy protocols for advanced cancer cases
• Trained other medical professionals at Antalya Training and Research Hospital
• Focuses on evidence-based internal medicine and medical oncology pathways
• Registered specialist with a background in local clinical research leadership

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Associate Professor Nail Paksoy is a dual-certified specialist in both immunology and medical oncology, offering a unique perspective on immunotherapy treatments. He currently serves at Medipol Bahcelievler University Hospital in Istanbul.

• Holds ESMO Board Certification in Medical Oncology from Paris
• Completed a dedicated fellowship in Allergy and Immunology
• Published research on PSMA-based tumour burden and immunotherapy outcomes
• Serves as a sub-investigator for major international clinical trials with Roche and MSD

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital, specialising in the complex field of targeted therapies and immunotherapy.

• Editorial board member for BMC Cancer, a prestigious international peer-reviewed journal
• Published over 50 scientific articles on solid tumours and advanced cancer care
• Expertise in geriatric oncology, focusing on treatment for older cancer patients
• Member of the European Society for Medical Oncology (ESMO)
• Completed clinical observership at the University of Leicester in the United Kingdom

Associate Professor Ayse Irem Yasin is a certified European Society for Medical Oncology (ESMO) specialist with extensive international training from Cleveland Clinic and Harvard Medical School.

• Specialises in urological cancers, focusing on the latest immunotherapy protocols for prostate malignancy
• Holds the prestigious ESMO Board Certificate, a globally recognised mark of oncological excellence
• Completed advanced observerships at major clinical centres in Switzerland, Italy, and the USA
• Former specialist at Sisli Etfal Training and Research Hospital, managing high-volume cancer cases

Associate Professor Muhammed Mustafa Atci is a highly regarded medical oncologist at İstinye University Liv Hospital Topkapı, where he specialises in advanced cancer protocols.

• Holds a dual specialty in internal medicine and medical oncology with a focus on modern targeted therapies
• Acts as an Education Coordinator, training the next generation of oncology specialists in Turkey
• Active member of the American Society of Clinical Oncology (ASCO) since 2018
• Extensively published in peer-reviewed international journals on tumour biomarkers and survival outcomes